Alumis (ALMS) Common Equity (2023 - 2026)
Alumis (ALMS) posted quarterly Common Equity of $301.3 million for Q4 2025, up 15.84% year-over-year from $260.1 million in Q4 2024, and down 21.69% quarter-over-quarter from $384.8 million in Q3 2025.
Analysis
Alumis (ALMS) Common Equity (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported Common Equity for 3 consecutive years, with $301.3 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Common Equity rose 15.84% year-over-year to $301.3 million; the TTM figure through Dec 2025 stood at $301.3 million (up 15.84% YoY), while the FY2025 annual figure was $301.3 million, up 15.84% from the prior year.
- Common Equity retreated to $301.3 million in Q4 2025 per ALMS's latest filing, from $384.8 million in the prior quarter.
- Across five years, Common Equity topped out at $485.3 million in Q2 2025 and bottomed at -$438.8 million in Q2 2024.
- Historically, Common Equity has averaged $19.9 million across 3 years, with a median of $168.3 million in 2025.
- On a YoY basis, Common Equity climbed as much as 214.95% in 2024 and fell as far as 67.24% in 2024.
- Alumis' Common Equity stood at -$339.3 million in 2023, then surged by 176.67% to $260.1 million in 2024, then gained by 15.84% to $301.3 million in 2025.
- Business Quant data shows ALMS's Common Equity at $301.3 million in Q4 2025, $384.8 million in Q3 2025, and $485.3 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 8.42 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 6.76 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 2.61 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 5.17 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.35 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 9.79 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 757.49 Mn |
| 10 | Alumis | 1.42 Bn | 919.00 Mn | - | 452.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 452.16 Mn |
| Dec 31, 2025 | 301.30 Mn |
| Sep 30, 2025 | 384.77 Mn |
| Jun 30, 2025 | 485.33 Mn |
| Mar 31, 2025 | 168.31 Mn |
| Dec 31, 2024 | 260.10 Mn |
| Sep 30, 2024 | 348.39 Mn |
| Jun 30, 2024 | 492.82 Mn |
| Mar 31, 2024 | -385.93 Mn |
| Dec 31, 2023 | 125.00 Mn |
| Sep 30, 2023 | -303.07 Mn |
| Jun 30, 2023 | -262.35 Mn |